Invention Grant
- Patent Title: Indazoles used to treat estrogen receptor beta mediated disorders
- Patent Title (中): 吲唑用于治疗雌激素受体β介导的疾病
-
Application No.: US12529561Application Date: 2008-03-05
-
Publication No.: US07960563B2Publication Date: 2011-06-14
- Inventor: Christopher Norbert Johnson , David G Jones , Xi Liang , David Timothy MacPherson , Aaron B Miller , Antoinette Naylor , Steven James Stanway , Andrew Kenneth Takle , Giancarlo Trani
- Applicant: Christopher Norbert Johnson , David G Jones , Xi Liang , David Timothy MacPherson , Aaron B Miller , Antoinette Naylor , Steven James Stanway , Andrew Kenneth Takle , Giancarlo Trani
- Applicant Address: GB Greenford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Greenford, Middlesex
- Agent J. Scott Young
- Priority: GB0704407.6 20070307
- International Application: PCT/EP2008/052664 WO 20080305
- International Announcement: WO2008/107455 WO 20080912
- Main IPC: C07D231/56
- IPC: C07D231/56 ; A61K31/416
Abstract:
The present invention relates to novel indazole derivatives having pharmacological activity, processes for their preparation, compositions containing them and uses of these compounds in the treatment of estrogen receptor beta mediated diseases.
Public/Granted literature
- US20100087502A1 Indazoles Used To Treat Estrogen Receptor Beta Mediated Disorders Public/Granted day:2010-04-08
Information query
